Skip to content

Clinical trials

Schizophrenia trials in Malaysia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Schizophrenia Country / region: Malaysia Clear all

40 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20062
20073
20086
20094
20103
20113
20126
20134
20141
20161
20171
20181
20211
20221
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed30
Terminated9
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Otsuka Pharmaceutical Development & Commercialization, Inc.6
Janssen Research & Development, LLC5
Alkermes, Inc.3
AstraZeneca3
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.3
Sumitomo Pharma America, Inc.3
Sumitomo Pharma Co., Ltd.3
Boehringer Ingelheim2
Forest Laboratories2
Pfizer's Upjohn has merged with Mylan to form Viatris Inc.2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Schizophrenia40
Autistic Disorder1
Bipolar Disorder1
Disease1
Mania1
Metabolic Syndrome1
Psychotic Disorders1
Schizophrenia, Treatment-Resistant1

Trials

Showing 1 to 25 of 40. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.